Nine Masts Capital’s Hologic HOLX Stock Holding History

Nine Masts Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-224,606	Closed	-$17M	–	229
2026 Q1	$17M	Buy	224,606 +174,606	+349%	+$13.1M	2.45%	11
2025 Q4	$3.72M	Buy	+50,000	New	+$3.65M	0.64%	25
2025 Q3	–	Sell	-7,000	Closed	-$456K	–	93
2025 Q2	$456K	Buy	+7,000	New	+$420K	0.17%	58

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nine Masts Capital's HOLX Position: Q2 2026 in Review

Nine Masts Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 224,606 shares — an estimated $17M sold.

Nine Masts Capital first reported a position in HOLX in Q2 2025 and held it in 3 quarters. The position peaked at $17M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Nine Masts Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 224,606 Hologic shares in Q2 2026, an estimated $17M.
Nine Masts Capital first reported a position in Hologic in Q2 2025 and held it in 3 quarters.
Nine Masts Capital's Hologic position peaked at $17M in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.